1. [ANMCO/GICR-IACPR/SICI-GISE Consensus document: Clinical management of patients with stable coronary artery disease]
- Author
-
Carmine, Riccio, Michele Massimo, Gulizia, Furio, Colivicchi, Andrea, Di Lenarda, Giuseppe, Musumeci, Pompilio Massimo, Faggiano, Maurizio Giuseppe, Abrignani, Roberta, Rossini, Francesco, Fattirolli, Serafina, Valente, Gian Francesco, Mureddu, Pier Luigi, Temporelli, Zoran, Olivari, Antonio Francesco, Amico, Giancarlo, Casolo, Claudio, Fresco, Alberto, Menozzi, and Federico, Nardi
- Subjects
Adrenergic Antagonists ,Anti-Inflammatory Agents, Non-Steroidal ,Cardiovascular Agents ,Coronary Artery Disease ,Calcium Channel Blockers ,Severity of Illness Index ,Treatment Outcome ,Italy ,Humans ,Patient Compliance ,Drug Therapy, Combination ,Angioplasty, Balloon, Coronary ,Coronary Artery Bypass ,Platelet Aggregation Inhibitors - Abstract
Stable coronary artery disease is of epidemiological importance. It is becoming increasingly common due to the longer life expectancy, being strictly related to age and to advances in diagnostic techniques and pharmacological and non-pharmacological interventions.Stable coronary artery disease encompasses a variety of clinical and anatomic presentations, making the identification of its clinical and anatomical features challenging. Therapeutic interventions should be defined on an individual basis according to the patient's risk profile. To this aim, management flow-charts have been reviewed based on sustainability and appropriateness derived from recent evidence. Special emphasis has been placed on non-pharmacological interventions, stressing the importance of lifestyle changes, including smoking cessation, regular physical activity and diet. Adherence to therapy as an emerging risk factor is also discussed.
- Published
- 2016